Seelos therapeutics to participate in the 2021 jefferies virtual healthcare conference

New york, may 10, 2021 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the 2021 jefferies virtual healthcare conference, june 1-4, 2021. raj mehra, ph.d.
SEEL Ratings Summary
SEEL Quant Ranking